Despite a flurry of merger and acquisition activity, the markets ended lower with the Dow falling 41 points to 17,071 as pro-democracy demonstrations demanded the resignation of Hong Kong chief executive C. Y. Leung. Nasdaq lost 6 points to 4,505
On the upside
Clovis Oncology (Nasdaq: CLVS) reported positive preliminary results from ongoing Phase 2 studies of its ovarian cancer treatment rucaparib.
GoPro (Nasdaq: GPRO) introduced three new Hero cameras.
The Food and Drug Administration approved Alimera Sciences' (Nasdaq: ALIM) diabetic macular edema treatment Iluvien.
On the downside
USEC (NYSE: USU) filed its monthly operating report with the SEC.
Polls indicating that Brazilian President Dilma Rousseff was pulling ahead of business friendly challenger Marina Silva weighed down shares of Banco Bradesco (NYSE: BBD) and Itau Unibanco (NYSE: ITUB).
CyberArk (Nasdaq: CYBR) closed its initial public offering.
In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on the NYSE and by 9 to 7 on Nasdaq. The broader S&P 500 lost 5 points to 1977. Bitcoin edged down a fraction to $372.
Lower close as protests continue in Hong Kong
September 29, 2014 at 17:57 PM EDT